Together Pharma Ltd (TGTR.TA)
ILA 421.9
(-1.29%)
ILA 421.9
(-1.29%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 25.7 Million ILS | -30.52% |
| 2022 | 36.99 Million ILS | -4.77% |
| 2021 | 38.84 Million ILS | -25.74% |
| 2020 | 52.31 Million ILS | 412.95% |
| 2019 | 10.19 Million ILS | 222.45% |
| 2018 | 3.16 Million ILS | 0.0% |
| 2017 | - ILS | -100.0% |
| 2016 | 2.93 Million ILS | 0.0% |
| 2015 | - ILS | -100.0% |
| 2014 | 5.48 Million ILS | 0.0% |
| 2013 | - ILS | 0.0% |
| 2012 | - ILS | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 13.07 Million ILS | -49.12% |
| 2024 Q2 | 13.07 Million ILS | 0.0% |
| 2023 Q4 | 25.7 Million ILS | -29.38% |
| 2023 FY | 36.39 Million ILS | -1.62% |
| 2023 Q1 | 30.54 Million ILS | -17.45% |
| 2023 Q2 | 30.54 Million ILS | 0.0% |
| 2023 Q3 | 36.39 Million ILA | 19.17% |
| 2022 Q3 | 36.99 Million ILS | 5.11% |
| 2022 Q4 | 36.99 Million ILS | 0.0% |
| 2022 Q1 | 35.2 Million ILS | -9.4% |
| 2022 FY | 36.99 Million ILS | -4.77% |
| 2022 Q2 | 35.2 Million ILS | 0.0% |
| 2021 Q4 | 38.84 Million ILS | 124.07% |
| 2021 Q3 | 17.33 Million ILS | 1.01% |
| 2021 Q2 | 17.16 Million ILS | -3.93% |
| 2021 FY | 38.84 Million ILS | -25.74% |
| 2021 Q1 | 17.86 Million ILS | -65.85% |
| 2020 Q4 | 52.31 Million ILS | 0.0% |
| 2020 Q1 | - ILS | -100.0% |
| 2020 Q2 | 41.69 Million ILS | 0.0% |
| 2020 FY | 52.31 Million ILS | 412.95% |
| 2019 FY | 10.19 Million ILS | 222.45% |
| 2019 Q4 | 10.19 Million ILS | 0.0% |
| 2019 Q3 | 10.19 Million ILS | 212.09% |
| 2019 Q2 | 3.26 Million ILS | 0.0% |
| 2019 Q1 | 3.26 Million ILS | 3.32% |
| 2018 Q3 | 3.16 Million ILS | -90.48% |
| 2018 FY | 3.16 Million ILS | 0.0% |
| 2018 Q4 | 3.16 Million ILS | 0.0% |
| 2018 Q1 | 33.24 Million ILS | 0.0% |
| 2018 Q2 | 33.24 Million ILS | 0.0% |
| 2017 Q1 | - ILS | -100.0% |
| 2017 Q4 | - ILS | 0.0% |
| 2017 Q3 | - ILS | 0.0% |
| 2017 Q2 | - ILS | 0.0% |
| 2017 FY | - ILS | -100.0% |
| 2016 FY | 2.93 Million ILS | 0.0% |
| 2016 Q4 | 2.93 Million ILS | 1.18% |
| 2016 Q3 | 2.89 Million ILS | -50.06% |
| 2016 Q2 | 5.8 Million ILS | 1.12% |
| 2016 Q1 | 5.73 Million ILS | 0.0% |
| 2015 FY | - ILS | -100.0% |
| 2015 Q4 | - ILS | 0.0% |
| 2015 Q3 | - ILS | 0.0% |
| 2015 Q1 | 5.79 Million ILS | 5.73% |
| 2015 Q2 | - ILS | -100.0% |
| 2014 Q1 | - ILS | 0.0% |
| 2014 FY | 5.48 Million ILS | 0.0% |
| 2014 Q4 | 5.48 Million ILS | 9.52% |
| 2014 Q2 | 4.49 Million ILS | 0.0% |
| 2014 Q3 | 5 Million ILS | 11.25% |
| 2013 Q2 | - ILS | 0.0% |
| 2013 Q4 | - ILS | 0.0% |
| 2013 FY | - ILS | 0.0% |
| 2013 Q1 | - ILS | 0.0% |
| 2013 Q3 | - ILS | 0.0% |
| 2012 FY | - ILS | 0.0% |
| 2012 Q3 | - ILS | 0.0% |
| 2012 Q4 | - ILS | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cannabotech LTD | - ILA | -Infinity% |